The length of time this story has been developing is easily forgotten. When Bayer acquired Monsanto in 2018, it inherited what many analysts at the time described as a good deal. Within a year, the deal had changed as the first significant jury verdicts began to come in.

Observing it now, it seems that Bayer misjudged how obstinate American juries can be when the plaintiff is a sixty-year-old gardener with non-Hodgkin lymphoma and a garage full of partially used spray bottles. The majority of what’s left will be covered by the recently proposed settlement, which was filed in Missouri earlier this year. The company has been the target of about 200,000 claims. Since 2015 alone, over 125,000 of those have been filed.

Approximately 77,000 had already been settled in two previous, independent settlements. However, new claims continue to come in: those who were diagnosed last year, those who were diagnosed the year before, and those who are just now making the connection between years of weekend yard work and a blood cancer diagnosis.

The disparity in the distribution of the funds is striking. An agricultural worker who has been sprayed for years and is diagnosed with an aggressive form of the disease before turning 60 may be eligible to receive up to $165,000. $20,000 could be awarded to a weekend homeowner with a milder variant who is in their seventies. $10,000 for someone who is 78 years of age or older.

The lawyers argue most loudly about that. Nearly 280 plaintiffs are represented by Matt Clement, who has already stated that he believes the payouts are far too small and that many of his clients will choose not to participate. The difference between what a Georgia jury awarded one plaintiff last year ($2.1 billion) and what the typical claimant will quietly accept on paper is difficult to ignore.

The Supreme Court, which is in charge of everything, is another. Monsanto v. Durnell, a case centered on a Missouri man named John Durnell who won $1.25 million after developing lymphoma as a result of years of neighborhood cannabis spraying, was agreed to be heard by the justices. FIFRA, a federal pesticide law, preempts state courts from requiring cancer warnings that the EPA never mandated, according to Bayer’s limited but profoundly significant argument.

A whole class of failure-to-warn lawsuits, not only against Roundup but also against the majority of pesticides sold in America, might simply disappear if Bayer prevails.

The company appears to have the advantage, according to investors. In contrast to the previous administration, the Trump administration has filed in Bayer’s favor. State legislation protecting pesticide producers who adhere to federal labels has already been passed in North Dakota and Georgia. By the end of 2026, Bayer might finally have the legal closure it has been seeking for almost ten years. It’s also possible that the settlement is upheld if the court makes a different decision, leaving the business vulnerable once more.

The checks continue to be sent out for the time being. Silently, one case at a time. And somewhere, a farmer is probably not even looking at the label as he loads another jug into the back of his truck.

The post The Roundup Cancer Settlement Is Still Paying Out — and Thousands of New Claims Are Still Being Filed appeared first on Creative Learning Guild.

There is a feeling that the trade association would prefer to write a sizable check rather than spend another ten years defending itself in front of juries after suffering two years of courtroom setbacks and a collapsing buyer-agent commission narrative.

If the court approves the agreement, a wide range of parties would be released from liability, including agents, state and local associations, REALTORS®-affiliated and non-affiliated MLSs, and brokerages whose principals possess a NAR membership card.

That is the largest umbrella that NAR has ever obtained. In her statement, CEO Nykia Wright emphasized this point, describing it as “a broader level of protection and release for the industry than has been secured in any previous NAR settlement.” It sounds like a line that a general counsel has been practicing for months.

No one’s actual working methods are altered by the agreement. No new guidelines for practice. No new checklist for compliance. The framework established following Sitzer/Burnett will still be used by brokers and agents; buyer agreements must be signed prior to showings, compensation must be disclosed up front, and cozy offers of cooperation cannot be hidden inside MLS listings.

The daily routine of American home purchasing has already been impacted by those changes, sometimes in an awkward way. When you visit an open house in Tampa or Phoenix, you’ll see that buyers now inquire about fees in a manner that they just didn’t three years ago. Commissions are no longer the subject of silence, most likely forever.

The payment schedule is a silent tale unto itself. The majority of the $52.25 million is not due until after June 2028, which is conveniently after NAR completes the payment of its Sitzer obligations in February of that same year. In order to give the industry enough time to absorb the pain, the organization is stacking its settlements like a homeowner refinancing debt.

It is more difficult to determine whether members view it that way. The sentiment on local boards varies from weary pragmatism to something more akin to resentment as dues-paying agents have witnessed their trade group absorb nearly half a billion dollars in settlements over the course of two years.

Together with the plaintiffs in the ongoing Batton case, the Tuccori plaintiffs made the straightforward but harmful claim that NAR and its allies colluded to keep commissions artificially high, driving up home prices for buyers who had no real means of negotiating. Earlier this year, Keller Williams paid $20 million to settle the Batton claims. Two weeks ago, REMAX reached a settlement of $8.5 million. Douglas Elliman has also expressed interest in joining the Tuccori framework, despite facing its own lawsuit.

It’s difficult to ignore how much the ground has changed. A few years ago, buyer-agent commissions were ingrained in every closing statement across the nation and were regarded as a natural law. They are currently the focus of regulatory attention, federal litigation, and a gradual, uncomfortable public reckoning. It’s still unclear if $52.25 million truly closes the chapter or simply opens a new one.

The post The $52.25 Million Real Estate Shockwave: Inside the Settlement Upending Homebuyer Commissions appeared first on Creative Learning Guild.

It’s difficult to ignore the shift in the atmosphere surrounding INTC, which seems more psychological than mathematical. On April 23, you could witness the scramble in real time by watching the after-hours trading. The price rose above $66 and briefly touched $80.58 before settling. The market capitalization was close to $302 billion.

That is not a figure associated with a business that investors still view as flawed. The question changed at some point between the previous earnings cycle and this one. There was no longer any question about Intel’s survival on the analyst calls. They were making a more difficult request. Could the demand for AI CPUs really finance Intel’s aspirations?

Bulls are clinging to the Data Center and AI segment, which increased 22% year over year to $5.1 billion. Additionally, it’s the part that allows Intel to participate in a discussion it was previously excluded from for the first time in a long time. Nvidia remains at the top of the market-cap mountain, and according to Polymarket prediction markets, there is a 90% chance that Nvidia will be the biggest company by June 30. It says something that those odds haven’t changed much.

The Intel beat is seen by traders. They simply don’t think it poses a threat to Nvidia’s position just yet. The conviction on the other side is strong, and it would take about $48,000 in new volume to move those odds by even five percentage points.

Even so, there’s a feeling that something is coming loose. A year ago, the narrative surrounding Intel’s government-backed positioning as America’s onshore semiconductor champion didn’t carry as much weight. The construction cranes at Intel’s Ocotillo campus in Arizona convey a story that the press releases fail to adequately convey. When the White House discusses domestic chip manufacturing, CEOs frequently bring up Intel for a reason. That position is gradually being priced in and has significant political and economic implications.

Intel Foundry is the issue, and it’s a real one. Although the segment’s 16% revenue growth makes for a compelling headline, it also recorded a $2.44 billion operating loss. It’s not a rounding error. The benefits of the better quarters are still being absorbed by Foundry. Bulls contend that this is the price of developing an American substitute for TSMC.

Opponents contend that losses are outpacing customer gains. Real evidence can be cited by both parties. The company’s SEC filings provide information on how Intel’s financial structure has changed that isn’t included in the quarterly decks.

The way Intel stories typically develop is worth mentioning. Over the past ten years, the company has been declared finished several times, but each time something came back to life. Perhaps this is the reason for the current rally’s slightly uneasy vibe. Investors recall the years 2019 and 2021, when hope first appeared and then subtly vanished. The Q1 beat is believable. The rerating is still ongoing.

Whether this rally continues or ends will depend on what transpires between now and the next earnings cycle, particularly any announcements related to onshore production or deeper partnerships with Nvidia and Amazon. For the time being, Intel has acquired something it hasn’t had in a long time. Pay attention. Additionally, attention may be more important than numbers for a business attempting to repair its reputation piece by piece.

The post The Quiet Comeback: Inside INTC Stock’s Most Surprising Quarter in Years appeared first on Creative Learning Guild.

You get the impression that the company has literally rediscovered its own name when you stroll through its Milpitas headquarters. The building’s glass entrance still has a brand-new, pixel-inspired logo that appears to have just been applied.

The noise is explained by the numbers. Last year, Sandisk was the S&P 500’s top-performing stock, and 2026 hasn’t exactly slowed things down. Over the last 12 months, shares have increased by about 2,963%, a number that typically belongs to cryptocurrency tokens rather than 40-year-old semiconductor companies. It’s difficult to ignore how peculiar that trajectory is, particularly for a company whose product—flash memory—most customers hardly consider unless they’re purchasing a microSD card at Best Buy.

Beneath the rally, however, is something more realistic than exaggeration. A real, quantifiable memory bottleneck has been created by the expansion of AI infrastructure, and Sandisk just so happens to be in a useful position inside that squeeze.

The most recent quarter saw a sequential 64% increase in data center revenue. The increase in gross margins to 51.1% indicates pricing power rather than just zeal. Memory manufacturers are purchasing NAND flash at a rate not seen in years thanks to hyperscalers, the enormous cloud operators expanding their AI capabilities.

Analysts have been racing to catch up. On April 9, Mark Newman of Bernstein increased his price target to $1,250, which at the time appeared almost theatrical because the stock was trading close to $850. On the same day, Cantor Fitzgerald and Mizuho added their $1,000 calls. Somewhere between $1,000 and $1,200, Bank of America, Evercore ISI, and Jefferies joined the chorus within the next week. The memory story seems to have moved from speculation to consensus, which historically is both encouraging and concerning.

since nothing travels in a straight line. SNDK is currently roughly fifty dollars below its 52-week high of $965 after falling 0.87% on April 20 and more than 5% since April 14. While stochastic oscillators have switched to “Hold” and “Sell” on shorter timeframes, technical indicators are still generally bullish. It’s the kind of cooling you would anticipate following such a strenuous run. Nobody is really sure yet if it’s a top or a pause.

The narrative’s rapid solidification is remarkable. Sandisk was mostly unseen by ordinary investors during his nearly ten-year tenure at Western Digital. When the spin-off was announced in 2023, it seemed like a mature hardware company cleaning up its balance sheet. Rather, it opened something. David Goeckeler left WD to lead the new company, and Western Digital, which still owns equity, has been gradually reducing its ownership to roughly $1 billion by early 2026.

The consensus estimate for the company’s fourth-quarter earnings is $18.78, but Newman believes it could be closer to $25.30. The amount of disagreement that still exists beneath the rally’s surface can be inferred from that gap alone.

Investors appear to think there is still potential for the AI memory cycle. The historically harsh cyclicality of NAND is cited by skeptics. Eventually, both might be correct. For the time being, Sandisk is doing what its founders most likely envisioned when they were just three engineers wagering on flash in 1988: being unavoidable.

The post From Spinoff to S&P 500 Superstar: The Sandisk Story Nobody Predicted appeared first on Creative Learning Guild.

It’s hard not to notice how quickly the tone around this brand has shifted. Not long ago, Lululemon was the kind of name analysts used as a benchmark. A stretch-fabric story that somehow kept working, through yoga booms and pandemic lockdowns and the rise of at-home fitness.

Now the questions are different. Why are markdowns becoming more common at stores that used to refuse to discount anything? Why does the product line feel, in the words of many shoppers, tired? And why is Alo Yoga, of all competitors, walking away with the cultural moment?

Laurent Vasilescu, the BNP Paribas analyst who titled his investor note “Uh-Oh’Neill,” made the case bluntly. He argued Lululemon needs a turnaround CEO, not a growth CEO. His logic rests on a simple read of O’Neill’s record at Nike, where she helped scale the business from $9 billion to $45 billion, largely through the direct-to-consumer push that Nike is now quietly backing away from.

The real question is whether that experience translates to a brand that is already at a standstill. Others, like Neil Saunders at GlobalData, pointed out her board seats at Spotify and Hyatt, suggesting she understands customer touchpoints beyond the product itself. Both might be correct. Both might be in error.

What makes the story more interesting is who’s watching from outside. Chip Wilson, the founder who still talks about the company as if he never fully left it, has been pressuring the board alongside Elliott Management, the activist investor that rarely shows up anywhere gently.

They’ve been lobbying for their own picks since December, when Calvin McDonald announced he was leaving. Neither has publicly commented on O’Neill’s appointment, which is itself a kind of comment. You can read more about the broader competitive pressure at Forbes if the brand-war context feels worth tracing.

Layered on top of this is the Texas attorney general’s investigation into alleged “forever chemicals” in the company’s workout gear, which Lululemon says it stopped using more than two years ago. Whether that distinction lands with shoppers, who tend to absorb headlines rather than footnotes, remains to be seen.

Outside the Vancouver headquarters, the business still runs. Stores still open. Managers, seventy percent of whom are promoted from within, still arrange displays and handle community events. The Canadian Olympic agreement is valid through the Summer Games in Los Angeles in 2028. The brand is intact. Simply put, it is no longer untouchable.

There’s a sense that this next phase, which O’Neill will take over in September, will determine whether Lululemon turns into the next Nike or the next cautionary tale that bar patrons tell each other. In the end, probably neither. Most likely somewhere in the middle. However, it appears that there is less space for error than there once was.

The post Lululemon Stock Falls 13%: Is the Athleisure King Losing Its Grip? appeared first on Creative Learning Guild.

The stock increased by 6.3%. Desks that had been drowsy moments before came to life. Suddenly, analysts in both Mumbai and New York were retrieving old notes about the drugmaker based in Hyderabad.

In a way, the story is familiar. These single-catalyst rallies, in which a regulatory hint from a foreign market propels a stock before anyone fully comprehends the fine print, frequently sweep up Indian pharmaceutical names. Preshant Nair of Citi, however, was not amused. He reaffirmed a sell, maintaining the company’s modest $50 million 2028 revenue projection for this specific medication while pointing out that at least five other players are already considering the same opportunity.

The discrepancy between what the sell-side is willing to underwrite and what the market appears to want to believe is difficult to ignore.

It seems like Dr. Reddy’s has always valued patience over zeal. The late Dr. Kallam Anji Reddy, a chemist who trained at the government-run Indian Drugs and Pharmaceuticals Limited before going it alone, founded the business in 1984. It expanded by starting with the less glamorous tasks. drugs in bulk. active components of pharmaceuticals. Western regulators hardly looked at exports to markets. It wasn’t until much later that it shifted to the challenging and costly game of obtaining FDA approvals and entering regulated territory.

By 2007, there were seven FDA-inspected facilities manufacturing APIs and seven more producing completed pharmaceuticals. The Biopharma Finished Dosage units in Hyderabad today have an industrial feel to them, unlike many Indian pharmaceutical campuses. The quality-control bays are lined with bins of rejected blister packs, the HVAC system hums, and the corridors are spotless.

For what they’re worth, the figures appear sound. Some value investors will interpret a P/E ratio of 17.63, which is close to the lower end of the company’s historical range, as a setup rather than a warning. A GF Score of 90 out of 100 indicates solid fundamentals in terms of growth, profitability, and financial strength.

For a business this size, the balance sheet is remarkably clean; a debt-to-equity ratio of 0.03 is the kind of number you typically see on a slide when management wants to brag. However, in the past 12 months, insiders have not purchased a share. Not one. which can mean something or nothing, depending on how you interpret it.

Money from institutions has been nibbling. In the fourth quarter, Rockefeller Capital Management strengthened its position. Russell Investments increased its ownership by over 800 percent. Then came smaller advisory firms. These trades aren’t particularly large, but they all follow the same pattern: a gradual, modest accumulation that occasionally precedes a re-rating and other times simply disappears into the background.

Semaglutide isn’t really what makes this moment intriguing. It’s that Dr. Reddy’s is once again being asked to demonstrate its ability to compete in a market where everyone has finally caught on. The bets that will matter in five years are the company’s research division in Atlanta, its push for biosimilars, and its covert expansion into dermatology and oncology.

There’s a sugar rush in the Canadian headline. The more difficult question is whether anyone can still be surprised by the methodical, patient culture that created this business. You get the impression that there won’t be a single press release with the solution as you watch it play out.

The post Dr Reddy Share Price Jumps on Semaglutide Buzz — But Is Wall Street Buying It? appeared first on Creative Learning Guild.

The National Park Service was sued federally by the ACLU of DC nine days later.

Earlier this year, Accountability NOW USA updated its display in response to a February NPR report that suggested the Justice Department had excluded Trump-related documents from the Jeffrey Epstein files’ public release. The new signs made reference to those purported ties; in particular, they used straightforward language to accuse the president of sexual misconduct. In the letter dated April 14, National Mall and Memorial Parks superintendent Kevin Griess stated that the content had been “evaluated under all appropriate standards and tests” and found to be unprotected by the First Amendment. He requested that it be taken down, cautioning that the Parks Service might take additional action to “ensure compliance.” Instead of running the risk of losing their permission to demonstrate at all, the group decided to cease displaying the signs because they perceived this as an immediate threat to their permit.

According to the ACLU, Griess’s decision has virtually no legal basis. The Miller test, a three-part standard that requires that the material appeal to prurient interest, depict sexual conduct in a way that is obviously offensive, and lack serious educational, artistic, political, or scientific value, is used by courts to define obscenity. The First Amendment does not protect obscenity. Each of the three requirements must be fulfilled. This standard is not met by political criticism of a president just because it makes reference to alleged sexual misconduct or uses harsh language. The government’s obscenity claim, according to ACLU of DC senior counsel Arthur Spitzer, is “so obviously manufacturing a legally frivolous ground for trying to take action against these demonstrators.” In a statement, the organization’s staff lawyer Laura Follansbee put it more succinctly: “Just because a Trump appointee finds a message distasteful does not make it illegal.”

The spokesperson for the Interior Department did not address the legal argument in their response. “As a reminder, we are approaching America’s 250th and we have visitors of all ages coming to our nation’s capital,” a spokesperson said. “This language is not protected under the First Amendment.” It is important to note that the Miller test does not contain a “visitors of all ages” clause. This framing, which frames an age-appropriateness issue as a constitutional determination, is precisely the kind of claim the ACLU is contesting in court.

Interior Secretary Doug Burgum and Griess are named as defendants in the lawsuit, which requests that the court rule that the signs are constitutionally protected, forbid the revocation of permits due to their display, and permit the group to continue displaying them. Additionally, the complaint situates the incident within a larger pattern that it characterizes as Washington’s systematic repression of political protest. It mentions the removal of a satirical sculpture of Trump and Jeffrey Epstein holding hands from the National Mall earlier this year, the detention of a man who performed the “Imperial March” behind National Guard troops, and the dismantling of a decades-long peace vigil near the White House in September 2025.

It’s difficult to ignore the fact that all of these incidents involve government-issued permits and government-owned property, indicating that the administration controls the venue and, presumably, also determines what forms of expression are permitted there. That is a noteworthy assertion. That arrangement was one of the reasons the First Amendment was drafted. The federal court’s decision and whether or not it finds the government’s obscenity determination to be even remotely credible will reveal the current state of the legal boundaries of executive authority over public expression.

The protest group has stated that as soon as it is granted legal protection, it plans to put up the signs once more. No revocation of the permit has occurred. Both parties are awaiting the outcome of the case, which is currently pending in federal court.

The post The ACLU Lawsuit Against the National Park Service Is the First Amendment Fight Washington Didn’t Want appeared first on Creative Learning Guild.

Since March 2026, the dispute between Bugatti Miami, a division of Braman Motors, and Bugatti of the Americas has been moving through the Florida courts and is currently under federal jurisdiction. The complaint presents a narrative that begins with numbers and concludes with what the dealer describes as reprisals. Bugatti Miami asked for and was granted permission to raise the warranty parts reimbursement rate from 100.49 percent to 160 percent in October 2024. Apparently, that was acceptable. The labor aspect of the problem was more controversial. After negotiating a deal to pay $1,100 per hour through the second half of 2025 and $1,350 starting on January 1, 2026, the dealership was able to secure $1,350 per hour for warranty work.

Then, on February 11, 2026, Bugatti of the Americas wrote to Braman Motors to let them know that the company was completely waiving the dealer’s obligations to perform warranty work because of what it called “excessive labor rate and parts markup.” The dealer described it as unilaterally taking away a contractual right, while Bugatti described it as releasing the dealer from an obligation. There is more to the distinction than just semantics. According to Bugatti Miami’s lawsuit, the automaker informed them that it could get the same level of service from other retailers for significantly less money and that it intended to inform nearby Bugatti owners that warranty servicing would no longer be offered at the Braman dealership. Bugatti has stated that it will not reimburse any warranty work completed on or after May 13, 2026. The revocation is set to take effect on May 12, 2026.

The allocation claim shifts the focus of the argument from labor economics to something more intimate. According to Bugatti Miami, it was only given two Tourbillon allocation slots. Nine were reportedly given to Bugatti Broward, which is about 25 miles up the coast. That difference amounts to about $28 million in potential revenue at $4.1 million per car, and in a market as wealthy as South Florida, allocation choices are very important. The complaint portrays this discrepancy as discriminatory, implying that rather than any justifiable business calculation, the inventory imbalance was related to the ongoing labor rate dispute.
The lawsuit goes even farther, claiming that Bugatti of the Americas has been engaging in direct-to-consumer sales in a way that violates Florida’s franchise laws by accepting reservations for particular VINs, determining purchase prices, and directly negotiating deal terms with buyers. This is a different but related issue that touches on the long-standing conflict between luxury and supercar manufacturers who want complete control over the customer relationship and the state franchise laws that exist, in part, to prevent that.

It is truly challenging to fully assign blame without seeing the dealer agreement and all pertinent correspondence when you watch all of this unfold from the outside. It’s possible that Bugatti has a good case that its warranty obligations to customers are being jeopardized by pricing that no other authorized partner charges, and that $1,350 per hour crosses a line that the agreement never anticipated. It’s also possible that years of authorized rate increases were followed by an abrupt reversal that conveniently coincided with the conclusion of the labor dispute, as the complaint argues. Both statements may be partially accurate. For this reason, rather than being resolved over a handshake in a Brickell conference room, these cases usually wind up in federal court.

The case raises important issues for the larger luxury and hypercar market. Something in the underlying economic model needs to be looked at if a company that manufactures $4 million machines can’t agree with its own authorized dealer about how much qualified technicians in one of America’s most expensive real estate markets should be paid per hour to service those machines. Neither side was prepared to offer an opinion. Presumably, the vehicles are still being driven.

The post The Bugatti Miami Service Lawsuit Reveals Something Uncomfortable About How Hypercars Actually Work appeared first on Creative Learning Guild.

The bills arrive at an intriguing time. Major oil producers have been sued by more than 70 states, counties, and cities nationwide for climate accountability, alleging that they have been deceiving the public about their knowledge for decades. There is one in Honolulu. There is one in Boulder, Colorado. Rhode Island does the same. Although none have yet made it to a jury, the industry appears anxious, and pressure is mounting.

There’s a particular kind of legislation that moves quietly through statehouses, the kind that rarely draws cameras or protests because its language is dry enough to bore a law student. The Oklahoma bill is one of those. So is the one in Utah. Read either of them quickly and you might miss what’s actually happening, which is that two red states are trying to make it nearly impossible for anyone inside their borders to drag an oil company into civil court over the climate crisis.

The bills arrive at an interesting moment. More than seventy states, cities, and counties across the country have filed climate accountability lawsuits against major oil producers, accusing them of misleading the public for decades about what they knew. Honolulu has one. Boulder, Colorado has one. So does Rhode Island. None have reached a jury yet, but the pressure is building, and it’s hard not to notice how nervous the industry looks.

Jay Inslee, the former Washington governor who spent years as a trial attorney before entering politics, put it bluntly. He said the American jury system is the foundation of democracy and these bills are designed to keep ordinary citizens from ever sitting in judgment of oil executives. He also said something that stuck with me — that these corporate efforts are expressions of fear. Coming from a politician, that sounds like rhetoric. Coming from a former litigator, it sounds like someone who has watched juries react to documents pulled from corporate files.

The federal version, introduced by Sen. Ted Cruz and Rep. Harriet Hageman, carries the almost theatrical name “Stop Climate Shakedowns Act of 2026.” Hageman framed it as a national security matter, arguing that American drilling shouldn’t be sabotaged by what she called leftist legal crusades. It’s a framing the industry has used for years. Energy security, national security, economic security — all stacked neatly on top of a provision that would retroactively neutralize lawsuits already filed.

Sixteen Republican state attorneys general asked the Justice Department last year for what they openly called a liability shield. Lobbying disclosures show ConocoPhillips and the American Petroleum Institute pressing Congress on draft legislation along similar lines. A failed bill in Maryland would have barred state and local climate suits entirely. None of this is happening by accident, and Richard Wiles of the Center for Climate Integrity said the quiet part out loud: if you haven’t broken the law, you don’t need immunity from lawsuits.

Legal scholars think the state bills, if passed, would face serious constitutional challenges. Pat Parenteau at Vermont Law School said blanket liability waivers tend to run into state constitutional protections for the right to seek redress. Michael Gerrard at Columbia pointed out that Oklahoma’s bill is the more aggressive of the two, targeting exactly the kinds of claims — fraud, deception, failure to warn — that sit at the heart of every climate accountability case currently moving through American courts.

Big Oil isn’t alone in this strategy. Pharmaceutical companies have pushed similar shields for pesticides, winning in Georgia and North Dakota. Tech firms are chasing the same kind of protection over AI-related harms. There’s a pattern, and it doesn’t require much squinting to see it. Advancements in attribution science, which can now link specific hurricanes and heat waves to fossil fuel emissions with growing precision, have made these lawsuits more dangerous to defendants than they were even five years ago. Parenteau sounded almost certain when he predicted that a multi-billion-dollar verdict was only a matter of time.

Whether these shield laws hold up in court is another question. Whether they pass at all depends on which way the Supreme Court moves on the Boulder case. But watching this unfold, there’s a feeling that something is shifting — not in the courtrooms yet, but in the corner offices Inslee mentioned. The industry is moving fast. That usually means it sees something coming. You’ve used 75% of your weekly limitGet more usage

The former governor of Washington, Jay Inslee, who worked as a trial lawyer for years before going into politics, put it plainly. He claimed that these bills are intended to prevent common people from ever sitting in judgment of oil executives and that the American jury system is the cornerstone of democracy. Additionally, he made a statement that really resonated with me: these corporate initiatives are manifestations of fear.

That sounds like rhetoric coming from a politician. It sounds like someone who has seen juries’ reactions to documents taken from corporate files, coming from a former litigator.

Sen. Ted Cruz and Rep. Harriet Hageman introduced the federal version, which is dubbed the almost theatrical “Stop Climate Shakedowns Act of 2026.” Hageman presented it as a national security issue, contending that “leftist legal crusades” shouldn’t undermine American drilling. The industry has been using this framing for years. Economic security, national security, and energy security are all neatly stacked on top of a clause that would nullify lawsuits that have already been filed.

Last year, sixteen Republican state attorneys general publicly requested a liability shield from the Justice Department. According to lobbying disclosures, ConocoPhillips and the American Petroleum Institute are exerting similar pressure on Congress regarding draft legislation. State and local climate lawsuits would have been completely prohibited by a failed Maryland bill. Richard Wiles of the Center for Climate Integrity made the quiet part clear: you don’t need immunity from lawsuits if you haven’t broken the law. None of this is happening by accident.

Legal experts believe there would be significant constitutional challenges to the state bills if they were approved. Blanket liability waivers typically conflict with state constitutional protections for the right to seek redress, according to Pat Parenteau of Vermont Law School. According to Michael Gerrard at Columbia, Oklahoma’s bill is the more aggressive of the two, focusing on the same allegations—fraud, deception, and failure to warn—that are at the core of every climate accountability case presently pending in US courts.

Big Oil is not the only company using this tactic. Similar pesticide shields have been pushed by pharmaceutical companies, who have been successful in North Dakota and Georgia. The same kind of protection against the negative effects of AI is being sought after by tech companies. It doesn’t take much squinting to notice the pattern. These lawsuits are now riskier for defendants than they were even five years ago due to developments in attribution science, which can now more precisely link certain hurricanes and heat waves to emissions from fossil fuels. When Parenteau said that a multibillion-dollar verdict was imminent, he sounded almost certain.

It remains to be seen if these shield laws are upheld in court. The Supreme Court’s decision in the Boulder case will determine whether they pass at all. However, as this develops, there’s a sense that something is changing in the corner offices Inslee mentioned, not in the courtrooms just yet. The sector is expanding quickly. This usually indicates that it anticipates something.

The post Shielding Big Oil: Why Republicans Are Rushing to Protect Corporations from Climate Litigation appeared first on Creative Learning Guild.

It’s possible that the market is at a loss for what to do with Disney. The 50-day moving average of $101.25 is stubbornly below the 200-day of $107.15, a technical detail that traders discreetly interpret as a drift rather than a recovery, despite the fact that the company still owns the most recognizable intellectual property on the planet—Marvel, Pixar, Lucasfilm, ESPN, the parks, the cruise ships, all of it. Investors seem to be waiting for something. a signal. A milestone in streaming profitability. An instance of Josh D’Amaro.

The change from Iger to D’Amaro, who assumed the CEO position earlier this year, felt less abrupt than the previous one. It matters that he is from Disney’s parks division, which continues to generate the majority of the company’s steady revenue.

When you stroll through Disney World on a Tuesday in April, you’ll notice that Space Mountain still has long lines, churros are still $8, and the park is somehow packed. The theme parks continue to support the company even though they don’t show up on earnings calls like streaming does.

The institutional funds have a narrative of their own. In the fourth quarter, Universal Beteiligungs und Servicegesellschaft, a company that most ordinary investors are unaware of, discreetly increased its Disney holdings by 3.9%, reaching over two million shares valued at approximately $239 million. More was added by Hudson Value Partners. More was added by Probity Advisors. Pavion Blue, Silver Coast, and Emerald are all moving up a tiny percentage. Institutional holders own about 65.71% of the stock, which may indicate confidence or just inertia. Sometimes it’s difficult to distinguish between the two.

It’s interesting that analysts can’t seem to agree. In a contradiction that seems very 2026, Guggenheim lowered its target from $140 to $115 while maintaining a buy rating. UBS described it as “mixed,” which is more of a shrug than a rating. Weiss was downgraded to hold. Needham made a buy and held firm at $125. Barclays remained overweight despite pulling from $140 to $130.

The consensus target of $133.53 suggests an upside of about 28%, which would be remarkable if it occurred and not surprising if it didn’t. One sell, five holds, and seventeen purchases.

It wasn’t a bad quarter. In contrast to projections of $25.54 billion, revenue was $25.98 billion. EPS of $1.63 was six cents higher than the consensus. Revenue increased by 5.2% year over year, which isn’t the kind of figure that makes Jim Cramer scream, but it’s genuine growth from an established company with an 8.90% return on equity. A healthy debt-to-equity ratio is 0.31. The balance sheet is in order.

Even so, there seems to be an unresolved issue. Quietly, streaming became profitable. For the third time in ten years, ESPN is reinventing itself. The film slate has been inconsistent, with some expensive failures concealed by a few hits. It’s difficult to ignore the fact that Disney, the company that spent a century telling the most assured stories in American entertainment, is now facing a somewhat uncertain future. Investors are essentially debating whether that uncertainty is priced in at $104 or whether it’s the start of something.

The post DIS Stock at a Crossroads: Why Wall Street Can’t Quite Agree on Disney appeared first on Creative Learning Guild.